Improving outcomes by reducing AKI in lung cancer surgery: introducing MERITS (Multi-centre Evaluation of Renal Impairment in Thoracic Surgery) (Englisch)
- Neue Suche nach: Naruka, V.
- Neue Suche nach: Khushiwal, R.
- Neue Suche nach: Clayton, J.
- Neue Suche nach: Aresu, G.
- Neue Suche nach: Peryt, A.
- Neue Suche nach: Mackay, J.
- Neue Suche nach: Coonar, A.
- Neue Suche nach: Naruka, V.
- Neue Suche nach: Khushiwal, R.
- Neue Suche nach: Clayton, J.
- Neue Suche nach: Aresu, G.
- Neue Suche nach: Peryt, A.
- Neue Suche nach: Mackay, J.
- Neue Suche nach: Coonar, A.
In:
Lung cancer
;
127
, s1
;
S88
;
2019
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Improving outcomes by reducing AKI in lung cancer surgery: introducing MERITS (Multi-centre Evaluation of Renal Impairment in Thoracic Surgery)
-
Beteiligte:Naruka, V. ( Autor:in ) / Khushiwal, R. ( Autor:in ) / Clayton, J. ( Autor:in ) / Aresu, G. ( Autor:in ) / Peryt, A. ( Autor:in ) / Mackay, J. ( Autor:in ) / Coonar, A. ( Autor:in )
-
Erschienen in:Lung cancer ; 127, s1 ; S88
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2019
-
Format / Umfang:S88
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99424
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99424 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 127, Ausgabe s1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- S1
-
Chloropyramine increases NSCLC sensitivity to cisplatin in a SASH1 dependent mannerBurgess, J. / Bolderson, E. / Adams, M. / Zhang, S. / Fox, S. / Wright, G. / Young, R. / Solomon, B. / Gray, S. / Richard, D. et al. | 2019
- S2
-
Collaborative genomics for improved patient care; a lung cancer case reportDu Parcq, P. / Harper, J. / Khorashad, J. et al. | 2019
- S3
-
National Optimal Lung Cancer Pathway implementation: can pathologists comply with turnaround times?Lloyd, K.L. / Rice, A. / Robertus, J.L. / Brambilla, C. / Popat, S. / Kemp, S. / Newsom-Davis, T. / Shah, P. / Nicholson, A.G. et al. | 2019
- S4
-
Understanding current lung cancer service to drive improvements towards achieving the national optimal lung cancer pathway at a busy district general hospitalEl-Nayal, A. / Southern, J. / Cocker, A. / Abdulla, A.C. / Aung, T. et al. | 2019
- S5
-
Reducing pathway length in lung cancer by multidisciplinary intervention: Wolverhampton Intervention in Lung cancer Daily, 'The WILD project'Morgan, A. / Berair, R. / Mathew, S. / Lakin, K. / Tanner, K. / Jones, J. et al. | 2019
- S6
-
Impact of organisation and specialist service delivery on lung cancer outcomesAdizie, J. / Khakwani, A. / Beckett, P. / Hubbard, R. / Navani, N. / Harden, S. / Woolhouse, I. et al. | 2019
- S7
-
The impact of a curative intent bundle pathway in a lung cancer serviceGlynn, P. / Tattersall, D.J. / Sayeed, N. / Menezes, B. et al. | 2019
- S9
-
Glenfield pulmonary neuroendocrine tumour guidelinesWeaver, H. / Rathinam, S. et al. | 2019
- S11
-
Implementation of National Optimal Lung Cancer Pathway: an early experienceMoneke, J. / Khan, S. / Hussain, I. et al. | 2019
- S13
-
National Optimal Lung Cancer Pathway: implementation of a 'straight to CT' pathway at NUHBakewell, F. / Hodgkiss, M. / Perumpalath, B. / Wright-Morris, D. / Severn, H. / Anwar, S. et al. | 2019
- S14
-
Initial evaluation of calcium levels of patients with suspected lung cancerApthorp, C. / Ratnakumar, S. / Warakagoda, I. / Stavrakas, N. / Crooks, S. et al. | 2019
- S15
-
CT guided percutaneous transthoracic lung biopsy (PTLB), risk of pneumothorax and associated factorsGogokhia, A. / Hawkins, S.K. / Guhaniyogi, L. / Shiels, E. / Williamson, I. / Goyal, N. / Ionescu, A.A. et al. | 2019
- S16
-
CT texture analysis as a predictor of effectiveness of second line nivolumab in metastatic non-small cell lung cancerLadwa, R. / Roberts, K. / Maggacis, N. / O'Byrne, K. / Miles, K. et al. | 2019
- S18
-
Can the recommended mediastinal staging performance standards for endosonography be met in everyday clinical practice?Barker, A. / Meek, D. / Hardy, C. / Carroll, N. / Rintoul, R. et al. | 2019
- S21
-
An evaluation of targets in lung cancer 2-week-wait pathway: closing the loop to the Quality Improvement Project at Great Western Hospital SwindonHameed, F. / Mackinlay, C. / Smith, R. / Masterman, B. / Ali, S. et al. | 2019
- S22
-
Results from a prevalence round of LDCT screening for lung cancer in the Lung Screen Uptake TrialRuparel, M. / Dickson, J. / Quaife, S. / Sophie, T. / Hall, H. / Horst, C. / Taylor, M. / Ahmed, A. / Shaw, P. / Burke, S. et al. | 2019
- S23
-
Prevalence of incidental interstitial lung disease in the Manchester lung cancer screening pilotBalata, H. / Hayton, C. / Barber, P.V. / Duerden, R. / Evison, M. / Greaves, M. / Howells, J. / Irion, K. / Karunaratne, D. / Leonard, C. et al. | 2019
- S24
-
Is tissue from stage 3 NSCLC suitable for biomarker evaluation?Smith, E. / Greystoke, A. / Iqbal, M.S. / Hanna, G. et al. | 2019
- S25
-
Do lung cancer outcomes vary by presenting symptom?Aslam, R. / Kennedy, M. / Bhartia, B. / Callister, M. et al. | 2019
- S27
-
Changes in performance status of lung cancer patients between respiratory and oncology clinicsDocherty, C. / Lin, Y.P. / Woodhouse, L. / Burke, E. / Patel, A.R.C. et al. | 2019
- S28
-
To talc or not to talc: can thoracoscopists accurately predict malignancy and trapped lung?Holme, J. / Rashed, A. / Chaudhry, A. / Mulla, A. / Wright, J. / Jackson, S. / Ahmed, M. / Evison, M. / Lyons, J. et al. | 2019
- S29
-
Indwelling pleural catheters in Fife: indications and outcomesBartlett, S. / Mackenzie, J. / Fairbairn, I. / Stevenson, M. et al. | 2019
- S30
-
Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA TrialKim, D. / Huber, R. / Ahn, M. / Langer, C. / Tiseo, M. / West, H. / Groen, H. / Reckamp, K. / Hochmair, M. / Leighl, N. et al. | 2019
- S31
-
The ALK project: a real-world national network and databaseGomes, F. / Yip, K. / Tokaca, N. / Greystoke, A. / Escriu, C. / Conibear, J. / Ghosh, S. / Doherty, G.J. / Funingana, I. / Ahmad, T. et al. | 2019
- S32
-
Real-world treatment patterns among adults with treatment-naive advanced non-small cell lung (aNSCLC) cancer in Europe: a systematic literature review (SLR)Gara, A. / Varol, N. / Goring, S. / Oviedo Ovando, M. / Li, T. / Hertel, N. et al. | 2019
- S33
-
Real-world outcomes with pembrolizumab in patients with treatment-naive advanced/metastatic NSCLC in the UK: multicentre retrospective observational studyTokaca, N. / Gomes, F. / Lau, S. / Jackson, A. / Gradwell, M. / Gyi, M. / Reinius, M. / Valentine, E. / Winn, E. / Bhosle, J. et al. | 2019
- S34
-
Relationship between body mass index (BMI), body composition and outcomes in patients receiving first line chemotherapy for advanced or metastatic non-small cell lung cancer (NSCLC): a single centre experienceHolden, C. / Macmillan, C. / O'Rourke, W. / West, M. / Wootton, S. / Jack, S. / Astin, R. / Grocott, M. / Nolan, L. / Cave, J. et al. | 2019
- S35
-
Multi-modality radical intent treatment in synchronous oligometastatic non-small cell lung cancer: how many patients complete the full treatment regime recommended by the MDT?Cheng, A. / Craig, C. / Summers, Y. / Taylor, P. / Califano, R. / Cove-Smith, L. / Woolf, D. / Duerden, R. / Sharman, A. / Lyons, J. et al. | 2019
- S36
-
Use of pembrolizumab in previously treated patients with advanced non-small cell lung cancer: the Kent Cancer Network experienceHunter, S. / Angelis, V. / Shah, R. et al. | 2019
- S37
-
Real world experience of third line docetaxel ± nintedanib post-nivolumab for treatment of metastatic NSCLC in the West of ScotlandRulach, R. / Mclaren, A. / Clark, B. et al. | 2019
- S40
-
Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world studyThakrar, D.B. / Essang, B. / Echlin, A. / Murdock, C. / Lind, M.J. et al. | 2019
- S41
-
Neutrophil-to-lymphocyte ratio (NLR) trends and treatment response to programmed death/ligand 1 (PD-1/PD-L1) inhibitors in non-small cell lung cancer (NSCLC)Yang, H. / Jayaprakash, K. Thippu / Aslam, S. / Jeffs, Y. / Jessop, S. / Mckay, N. / Cawood, H. / Bulusu, V.R. et al. | 2019
- S44
-
Outcome of NSCLC (non-small cell lung cancer) patients treated with second line pembrolizumab: experience from the Portsmouth Oncology CentreGyi, M.M. / Gulliford, T. / Muthuramalingam, S. et al. | 2019
- S45
-
Pembrolizumab monotherapy for advanced/recurrent non-small cell lung cancer: a Greater Manchester experienceTivey, A. / Wu, K.S. / Tay, R. / Gomes, F. / Taylor, P. / Blackhall, F. / Summers, Y. / Califano, R. / Cove-Smith, L. et al. | 2019
- S46
-
Immunotherapy outcomes based on PDL1 expression and tissue origin in NSCLCKhan, S. / Charalambous, M. / Khan, M. / Khalid, F. / Enver, M. / Ahmed, S. et al. | 2019
- S47
-
Does molecular analysis alter treatment options for patients in Wolverhampton?Jones, J. / Lakin, K. / Tanner, K. / Morgan, A. et al. | 2019
- S48
-
Does chemotherapy offer a survival benefit to NSCLC patients with a performance status of 2?Thompson, L. / Lee, C. / Burnett, A. et al. | 2019
- S49
-
An evaluation of the Irish Cancer Society's 2018 lung cancer awareness campaignMcnamara, A. / Saunders, R. / Krieger, C. et al. | 2019
- S50
-
The impact of the Lung Cancer Navigator on the MDTHugh, M. / Docksey, J. et al. | 2019
- S51
-
A retrospective 12 month audit of all lung cancer patients attending the Acute Oncology Assessment Unit at a Scottish Regional Cancer CentreDevenay, S. / Holmes, E. et al. | 2019
- S52
-
What do people living with and surviving lung cancer want and need from the Recovery Package?Roberts, J. / Tod, A. / Salim, F. / Collins, P. / Athey, V. et al. | 2019
- S53
-
Patient reported outcomes (PROs) in patients with extensive-stage small cell lung cancer receiving chemotherapy: a pilot project at a treatment tertiary oncology centreNeal, H. / Fenemore, J. / Eaton, M. / Mcentee, D. / Wray, D. / Tay, R. / Lindsay, C. et al. | 2019
- S55
-
Estimating renal function in lung cancer patientsGannon, K. / Ball, S. et al. | 2019
- S56
-
Pre-operative uptake of cardiopulmonary exercise test (CPET) in lung cancer surgery in WolverhamptonZahid, A. / Yip, K. / Pritchard, A. / Morgan, A. et al. | 2019
- S57
-
Effectiveness and tolerability of tyrosine kinase inhibitors as treatment for advanced non-small cell carcinoma (NSCLC) in the elderly: a real-world practice three-centre experienceSilva, N. / Goranov, B. / Parslow, D. / Chambers, J. / Talbot, T. / Dorey, N. / Toy, E. et al. | 2019
- S58
-
A framework for systematic clinical evaluation of technical innovations in lung cancer patients treated on the MR-linac (MRL)Cobben, D. / Bainbridge, H. / Belderbos, J. / Cheung, P. / Dubec, M. / Gomez, D. / Gore, E. / Knowles, E. / Lalezari, F. / Oelfke, U. et al. | 2019
- S59
-
Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag studyHochmair, M. / Cufer, T. / Morabito, A. / Hao, D. / Ta Yang, C. / Soo, R. / Yang, J. / Gucalp, R. / Halmos, B. / Wang, L. et al. | 2019
- S60
-
Lung cancer screening programmes: landscape in ChinaCheng, Y. / Davies, M.P.A. / Li, W. / Field, J.K. et al. | 2019
- S61
-
Pre-triage clinical questionnaire for patients on the National Optimal Lung Cancer PathwaySnook, S. / Earl, S. / Roy, A. / Daneshvar, C. et al. | 2019
- S62
-
Single-centre retrospective analysis of prognostic scores by the Royal Marsden Hospital (RMH) and the Gustave Roussy Institute (GRIm) in a Nottinghamshire population treated with immunotherapy for advanced non-small cell lung cancer (NSCLC)Lopez Escola, C. / Sheikh, O. / Franks, H. / Malton, S. / Gossage, L. / Khan, S. / Arora, A. / Hennig, I. et al. | 2019
- S63
-
Long-term follow-up of patients who had bronchial carcinoid tumours resected in a district general hospitalMccloskey, M. / Yarr, C. / Grant, K. / Doherty, M. / Sharkey, R. / Kelly, M. / Coulter, H. et al. | 2019
- S65
-
The impact of route of referral on treatment intent and survival in patients with lung cancer: results of a local surveyWoodhouse, L. / Lin, Y.P. / Burke, E. / Docherty, C. / Patel, A.R.C. et al. | 2019
- S66
-
Review of outcomes for patients with large cell neuroendocrine lung tumours in North East EnglandGault, A. / Greystoke, A. / Hughes, A. / Gardiner, J. et al. | 2019
- S67
-
Modified Lung Immune Predictive Index (mLIPI) as a predictive tool of nivolumab outcomes and immune related adverse events in advanced non-small cell lung cancer (NSCLC) patientsMoor, R. / O'Byrne, K. / Roberts, K. et al. | 2019
- S68
-
Prophylactic antibiotics following local anaesthetic thoracoscopy: do they have a role?Ahmed, M. / Jackson, S. / Lyons, J. / Evison, M. / Holme, J. et al. | 2019
- S69
-
Real-world experience with nivolumab and atezolizumab toxicities in advanced thoracic malignancies: a single centre experience in the UKChoy, J. / Chang, Y. / Newsom-Davis, T. et al. | 2019
- S71
-
Smoking patterns and attitudes to smoking cessation among patients actively receiving anti-cancer treatmentKeane, F. / Mullally, W. / Kieran, R. / O'Regan, S. / Nolan, A. / Aslan, R. / Hennessy, B. / Morris, P. / Grogan, L. / Breathnach, O. et al. | 2019
- S72
-
Outcomes after stereotactic ablative body radiotherapy for stage 1 lung cancerPhillips, I. / Chandy, E. / Yusof, H. / Lodge, D. / Bishop, L. / Mahendran, P. / Halling-Brown, M. / Saxby, H. / Ezhil, V. et al. | 2019
- S74
-
The impact of intra-thoracic anatomical changes upon the delivery of lung stereotactic ablative radiotherapyBrown, S. / Beasley, M. / Chuter, R. / Faivre-Finn, C. / Franks, K. / Henry, A. / Murray, L. / Van-Herk, M. et al. | 2019
- S75
-
Correlation of standardised uptake value (SUV) on fluorodeoxyglucose positron emission tomography scans with the development of metastatic disease in early-stage lung cancer treated with stereotactic ablative radiotherapy (SABR)Sambasivan, K. / Ahmad, S. / Hartill, C. / Smith, D. / Taylor, B. / Wilson, J. et al. | 2019
- S77
-
An audit of sequential chemoradiotherapy for non-small cell lung cancer (NSCLC) at the Leeds Cancer Centre (LCC)Sun, F. / Littlejohns, A. / Fakih, O. / Clarke, K. / Franks, K. / Snee, M. / Dickinson, P. / Jain, P. et al. | 2019
- S79
-
Patients with N3 non-small cell lung cancer (NSCLC) treated with radical chemoradiation can expect similar survival to patients with N2 diseaseGomberg, S. / Hiley, C. / Taylor, B. / Smith, D. / Ahmad, S. et al. | 2019
- S80
-
Tumour shape features are not the prognostic factors they appear to beDavey, A. / Van Herk, M. / Faivre-Finn, C. / Mistry, H. / Mcwilliam, A. et al. | 2019
- S81
-
Palliative lung radiotherapy at the Christie: audit of prescribing practice and survival analysisLewis, T. / Kennedy, J. / Price, G. / Mee, T. / Woolf, D. / Bayman, N. / Chan, C. / Coote, J. / Faivre-Finn, C. / Harris, M. et al. | 2019
- S82
-
An audit of thoracic radiotherapy in extensive stage small cell lung cancer delivered as per REST trial protocolIqbal, M.S. / Mian, A. / Bashir, S. / Haris, N. / Atherton, P. / Mcmenemin, R. / Cunnell, M. et al. | 2019
- S83
-
Determining the factors associated with 1-year survival in small cell lung cancer using national audit, chemotherapy and radiotherapy dataJones, G. / Khakwani, A. / Mckeever, T. / Hubbard, R. / Baldwin, D. et al. | 2019
- S84
-
Factors influencing treatment selection and prognosis in patients with small cell lung cancerIrshad, S. / Grove, P. / Jegannathen, A. / Hussain, I. / Bikmalla, S. et al. | 2019
- S85
-
The role of PCI in extensive stage small cell lung cancer treated with palliative chemotherapy and consolidative thoracic radiotherapyIqbal, M.S. / Mian, A. / Bashir, S. / Haris, N. / Mcmenemin, R. / Atherton, P. / Cunnell, M. et al. | 2019
- S87
-
Determining the feasibility and acceptability of a mobile health application to remotely monitor the symptoms of people with mesothelioma at homeMaguire, R. / Arber, A. / Klepacz, N. / Connaghan, J. / Mcphelim, J. / Blythe, K. / Murray, P. / Rupani, H. / Mcnaughton, L. / Moylan, A. et al. | 2019
- S88
-
Is a wedge resection a good surgical alternative to lobectomy?Burnside, N. / Zuccerelli, A. / Spence, D. et al. | 2019
- S89
-
Sheffield Prospective Single-Port VATS Quality of Life Cohort study (SP2QC)Hocknell, E. / George, H.A. / Gleeson, H.V. / Rao, J.N. / Socci, L. / Tenconi, S. / Hopkinson, D.N. / Edwards, J. et al. | 2019
- S90
-
Laser pulmonary metastasectomy preserves parenchyma: a single-institution study from the United KingdomChandarana, K. / Weaver, H. / Caruana, E. / Rathinam, S. / Nakas, A. et al. | 2019
- S91
-
Avoiding cardiac toxicity in patients undergoing curative intent radiotherapy for lung cancerBanfill, K. / Sun, F. / Mcwilliam, A. / Abravan, A. / Lilley, J. / Wheller, R. / Falk, S. / Schmitt, M. / Van Herk, M. / Franks, K. et al. | 2019
- S92
-
Rare double mutations in epidermal growth factor receptor (EGFR) mutant adenocarcinoma of lungThippu Jayaprakash, K. / Yang, H. / Aslam, S. / Jeffs, Y. / Jessop, S. / Bulusu, V.R. et al. | 2019
- S93
-
Iatrogenic tumour seeding (ITS) following a craniotomy for resection of oligometastatic non-small cell lung cancerMalek, A. / Khadka, S. / Islam, M.R. et al. | 2019
- S94
-
Rapid treatment reponse to pembrolizumab in non- small cell lung cancer (NSCLC)Plant, R. / Bayne, M. / Geldart, T. et al. | 2019
- S95
-
Experience with atezolizumab immunotherapy for a patient with non-small cell lung cancer on renal dialysisMahmood, A. / Chowdhury, S. et al. | 2019
- S96
-
Tomotherapy and tarceva: surviving ten years with stage IV lung cancerKeshwani, K. / Singer, J. / Chowdhury, S. et al. | 2019
- S98
-
Author Index| 2019
-
Audit of stage III non-small cell lung cancer (NSCLC) management in the Essex Cancer NetworkReinius, M. / Malek, A. / Powrie, D. / Yung, B. / Ingle, C. / Islam, M.R. / Dancey, G. et al. | 2019
-
A review of urgent suspected lung cancer referrals in Edinburgh Royal InfirmaryQuinn, T. / Skwarski, K. et al. | 2019
-
Peptide receptor radionuclide therapy for metastatic bronchopulmonary carcinoid tumours: a single ENETS Centre of Excellence experienceEvans, J. / Yang, W.M. / Newsom-Davis, T. / Sharma, R. et al. | 2019
-
Efficacy and safety of systemic treatment for older lung cancer patientsGandhi, R. / Kussaibati, R. / Powell, R. / Baijal, S. et al. | 2019
-
Clinical presentation and prognosis of high PD-L1 expressors in non-small cell lung cancerChin, I.S. / Yip, K.P. / Middleton, G. et al. | 2019
-
Psychological impact of low-dose CT screening in a 'real-world' demonstration lung cancer screening pilotKummer, S. / Waller, J. / Ruparel, M. / Janes, S. / Quaife, S. et al. | 2019
-
Achieving the National Optimal Lung Cancer Pathway: the role of the biomedical scientistRicketts, W. / Giaslakiotis, K. / Jeetle, S. / Wong, A. / Sheaff, M. et al. | 2019
-
Should smoking cessation be promoted in patients with advanced lung cancer: a literature reviewHugh, M. et al. | 2019
-
Acute kidney injury risk and prevention in patients undergoing treatment for lung cancerLewis, A. / Ladan, Z. / Al-Sayed, T. / Campbell, G. / Blackhall, F. et al. | 2019
-
Impact of radiographer immediate reporting of chest x-rays from general practice on the lung cancer pathway (radioX)Woznitza, N. / Devaraj, A. / Janes, S. / Duffy, S. / Rowe, S. / Bhowmik, A. / Maughn, S. / Piper, K. / Baldwin, D. et al. | 2019
-
EBUS in lung cancer staging and diagnosis: service performance across a cancer allianceMulla, A. / Al-Najjar, H. / Bailey, S. / Brown, L. / Martin, J. / Lyons, J. / Crosbie, P.A.J. / Booton, R. / Evison, M. et al. | 2019
-
Follow-up post lung cancer surgery; is there still a role for routine chest radiographs after completion of surveillance CT scans?Rowan, C. / Mccarthy-Bell, K. / Blaxill, P. / Ameri, A. et al. | 2019
-
Establishing a clinical sequencing program for lung cancer in a public hospitalO'Byrne, K. / Leo, P. / Ellis, J. / Clout, M. / Mcinerney-Leo, A. / Wheeler, L. / Anderson, L. / Brown, M. et al. | 2019
-
Quality outcome measures for single-port VATS resection of non-small cell lung cancerGeorge, H.A. / Gleeson, H.V. / Hocknell, E. / Rao, J.N. / Socci, L. / Tenconi, S. / Hopkinson, D.N. / Edwards, J.G. et al. | 2019
-
Retrospective analysis of the management of extensive stage small cell lung cancer (SCLC) in patients with a poor performance statusMoore, T. / Gossage, L. / Lopez Escola, C. / Hennig, I. et al. | 2019
-
A survey of the practice of stereotactic ablative radiotherapy for lung cancer in the UK on behalf of the Advanced Radiotherapy Technologies Network (ART-NET)Brown, S. / Beasley, M. / Mcnair, H. / Faivre-Finn, C. / Henry, A. / Van-Herk, M. et al. | 2019
-
Patient-reported outcome measures for lung cancer in daily clinical useDavies, G. / Collier, G. / Whatling, K. et al. | 2019
-
A retrospective case-control study to assess the impact of enhanced supportive care for patients with advanced lung cancerVijeratnam, N. / Stockley, A. / Godfrey, N. / Jenkins, E. / Dorey, N. / Toy, E. et al. | 2019
-
Improving psychological support for patients with lung cancer and mesothelioma: evaluation of three new nurse-led servicesIvey, S. / Partridge-James, T. / Powell, H. / Mehta, A. et al. | 2019
-
Lung cancer pathway: first consultation patient information leafletCanning, L. / Sparkes, H. / Al-Najjar, H. et al. | 2019
-
The value of the lung cancer nurse specialist in the development and implimentation of the local optimal lung cancer pathwayBennett, A. / Patrick, C. et al. | 2019
-
An audit on the use of osimertinib in T790M EGFR+ patients at West Suffolk HospitalDavis, O. / Patterson, D. / Martin, A. et al. | 2019
-
Is the current strategy for stratifying patients for targeted therapy use in NSCLC really logical and sustainable? Results from a retrospective study suggest otherwiseMoore, D. / Maddox, A. / Gillibrand, R. / Medeiros, F. et al. | 2019
-
Can 'Upfront' PET-CT reduce time to diagnosis in lung cancer target referrals?Verghese, P. / Elsheikh, A. / Mo, J. / Jain, S. / Powrie, D. et al. | 2019
-
CT as a tool for endobronchial stent size estimation: a district general hospital experienceSundaralingam, A. / Wilkinson, J. / Sharma, N. et al. | 2019
-
Liverpool Healthy Lung Project second year evaluation: deaths prevented and significant other findingsHill, S. / Ledson, M. / Grundy, S. / Gaynor, E. / Fidoe, D. / Mason, S. / Field, J.K. / Duffy, S. et al. | 2019
-
Immune-related adverse events in patients with stage IV non-small cell lung cancer on immunotherapy: experience from the West of ScotlandDownham, E. / Maclaren, V. / Mcloone, P. et al. | 2019
-
MARS-2 trial of extended pleurectomy/decortication for malignant mesothelioma: outcomes of screening groups from a surgical centreSharkey, A. / Broomes, N. / Socci, L. / Tenconi, S. / Stanley, H. / Hanratty, H. / Matthews, S. / Fisher, P. / Edwards, J. et al. | 2019
-
DGH experience of implementing NOLCP: day –3 to 0Spencer, E. / Ward, M. / Hugh, M. / Docksey, J. / Gill, C. et al. | 2019
-
PD-L1 testing in advance stage lung cancer using cytology samples: suitability and interobserver agreement. How well are we doing?Elshiekh, M. / Iles, S. / Hopcroft, D. / Trivedi, P. / Gupta, N. / Bhagwat, P. / Viola, P. et al. | 2019
-
Diagnostic yield and safety of EBUS-TBNA: single-centre experience of 500 patientsBaty, N. / Singh, R. / Lal, A. et al. | 2019
-
The utility of cfDNA as a diagnostic tool in the management of EGFR-mutated non-small cell lung cancer (NSCLC): our regional off-study experienceNageshwaran, S. / Ping, B. / Mehta, A. / Ezhil, V. / Feng, G. / Hall, J. / Shaheed, M. / Amin, N. / Faulkes, C. / Collins, N. et al. | 2019
-
An audit of pulmonary nodule workload and a proposed pathway in response to the recent BTS guidelinesWebb, P. / Rhodes, A. et al. | 2019
-
Do we adequately follow-up extrathoracic lesions identified on PET CT?Mendes, S. / Stockbridge, A. / Sultana, S. / Rashid, R. et al. | 2019
-
Evaluating an intervention to improve the two-week wait pathway times for patients with radiologically suspected lung cancers in a district general hospitalDexter, L. / Price, L. / Graves, J. et al. | 2019
-
Assess the benefits of Implementing regular nutritional screening for patients with a lung cancer diagnosisRushton, C. / Anderson, V. / Walton, A. et al. | 2019
-
Metachronous oligometastatic non-small cell lung cancer: are we selecting the appropriate patients for radical treatment?Cheng, A. / Craig, C. / Summers, Y. / Taylor, P. / Califano, R. / Cove-Smith, L. / Woolf, D. / Duerden, R. / Sharman, A. / Lyons, J. et al. | 2019
-
Audit of outcomes of patients with stage III NSCLC (TNM VII) who were treated with radical RT or high-dose palliative radiotherapy between January 2017 and July 2017Smith, E. / Aynsley, E. / Kumar, G. / Peedell, C. / Masinghe, S. et al. | 2019
-
Video-assisted thoracoscopicsurgical procedures using laryngeal mask (LMA) spontaneous ventilation anaesthesia: an early experience of a novel anaesthetictechniqueHussain, A. / Ayiomamitis, M. / Isaac, E. / Tentzeris, V. / Chaudhry, M. / Loubani, M. / Qadri, S. et al. | 2019
-
A case of hyperprogression of lung cancer following atezolizumabMuthukumar, D. / Saunders, E. / Rubasingham, J. / Nagarajah, V. et al. | 2019
-
Pembrolizumab in non-small cell lung cancer: our experienceRizvi, S.A. / Reza, S. / Kabba, T. / Ajzensztejn, D. / Dwyer, M. / Randhawa, R. / Karina, M. et al. | 2019
-
Editorial Board| 2019
-
Neuroendocrine cells in the lung: physiology and pathologyPink, G. / Mapfunde, I. / Lara, B. et al. | 2019
-
Early proactive referral identifies lung cancer patients with significant palliative care needsDroney, J. / Kano, Y. / Nevin, J. / Kamal, L. / Kennett, A. / Oloko, R. / Popat, S. / Wiseman, T. / Wood, J. / Stevens, A. et al. | 2019
-
Development of a lung consultant therapy radiographer and the impact on the stereotactic ablative radiotherapy pathway: the Northern Centre for Cancer care (NCCC) Newcastle experiencePickles, R. / Driver, S. / Atherton, P. / Iqbal, M.S. et al. | 2019
-
Lung cancer stigma: addressing it in clinical careMaguire, R. / Lewis, L. / Mcphelim, J. / Cataldo, J. / Milroy, R. / Wood, K. / Perham, M. et al. | 2019
-
Early experience from the Plymouth National Optimal Lung Cancer PathwaySnook, S. / Gunaratne, H. / Probyn, B. / Nicholson, T. / Corcoran, J.P. / Waine, D.J. / Howell, T.J. / Riordan, R. / Roy, A. / Daneshvar, C. et al. | 2019
-
A project to investigate and compare biopsy methods for lung cancer diagnosisPink, G. / Drought, J. / Yap, W.H. / Wu, J. et al. | 2019
-
Analysis of cytomorphology in NSCLC with specific epidermal growth factor (EGFR) mutationsBowden, R. / Al-Najjar, H. / Narine, N. / Shelton, D. / Wallace, A.J. / Bailey, S. / Karunaratne, D. / Rana, D. et al. | 2019
-
Testing of EGFR mutations, ALK translocations and PD-L1 expression in patients diagnosed with adenocarcinoma at Great Western Hospital, Swindon: a re-audit after reflex testing had been declinedGibson, V. / Khan, O. et al. | 2019
-
Optimising nodule management with data from the Lung Screen Uptake TrialHorst, C. / Ruparel, M. / Dickson, J. / Quaife, S. / Hall, H. / Tisi, S. / Taylor, M. / Ahmed, A. / Shaw, P. / Burke, S. et al. | 2019
-
Performance of endobronchial ultrasound-guided transbronchial needle aspiration in PD-L1 testing in patients with NSCLCPerrotta, F. / Nankivell, M. / Adizie, J. / Elshafi, M. / Jafri, S. / Maqsood, U. / Munavvar, M. / Woolhouse, I. / Lerner, A. / Evison, M. et al. | 2019
-
Radiological-pathological correlation of negative CT biopsy results enables high negative predictive value for thoracic malignancyBarnett, J. / Pulzato, I. / Padley, S. / Jordan, S. / Nicholson, A.G. / Rice, A. / Choraria, A. / Javed, M. / Lee, Y.J. / Kemp, S. et al. | 2019
-
An audit on the outcomes of patients with primary lung cancer treated with stereotactic ablative radiotherapy (SABR) at a single institute between 2013 and 2018Mccabe, A. / Foweraker, K. / Pascoe, A. et al. | 2019
-
Comparing outcomes of patients with epidermal growth factor receptor (EGFR) therapy resistant mutations (EXON 20 and T790M)Enver, M. / Khalid, F. / Khan, S. / Ahmed, S. et al. | 2019
-
The impact of COPD on lung cancer treatment and survivalLin, Y.P. / Docherty, C. / Burke, E. / Woodhouse, L. / Patel, A.R.C. et al. | 2019
-
The experience of immunotherapy in lung cancer: an audit of patients receiving first-line immunotherapy for metastatic small cell lung cancer in South Tees between June 2016 and December 2017Hairudin, T. / Li, L. / Mansy, T. / Aynsley, E. / Kumar, G. / Masinghe, S. / Peedell, C. et al. | 2019
-
Treatment patterns and outcomes for limited stage small cell lung cancer treated with chemoradiotherapySim, D. / Pascoe, A. / Foweraker, K. et al. | 2019
-
Case report: station 5 nodal sampling via conventional EBUS in the presence of ROSEDeacon, A. / Rana, D. / Irion, K. / Al-Najjar, H. et al. | 2019
-
National Lung Cancer Audit patient booklet impact assessment: an evaluationRodgers, H. / Scott, O. et al. | 2019
-
Developing, launching and evaluating a research network for mesotheliomaLenny, C. / Woods, P. / Moore-Gillon, J. et al. | 2019
-
The financial impact of establishing a comprehensive inpatient smoking cessation service: developing the CURE project in Greater ManchesterMulla, A. / Shackley, D. / Pearce, C. / Howle, F. / Elsay, L. / Evison, M. et al. | 2019
-
The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancerElmushraf, R. / Clinch, H. / Salawu, A. / Fisher, P. / Young, R. / Lee, C. / Danson, S. / Bates, E. / Hatton, M. / Low, L. et al. | 2019
-
First line anti-PD1 checkpoint inhibitor in the management of patients with advanced non-small cell lung cancer: the Kent Cancer Network experienceAngelis, V. / Hunter, S. / Shah, R. et al. | 2019
-
Yield of pleural fluid cytology in those with risk factors for malignant pleural mesotheliomaTrappes-Lomax, C. / Robson, J. et al. | 2019
-
PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastasesHaragan, A. / Gosney, J. / Field, J.K. / Davies, M. / Escriu, C. / Gruver, A. et al. | 2019
-
Defining COMMD4 as an anti-cancer therapeutic target and potential diagnostic biomarker in lung cancerSuraweera, A. / Adams, M. / Richard, D. / O'Byrne, K. et al. | 2019
-
Serum β-hCG in non-small cell lung cancer: a potential marker for early detection and assessing treatment response? A case reportKillean, A. / Sundaramurthy, A. / Malik, J. / Little, F. / Law, A. et al. | 2019
-
Improving outcomes by reducing AKI in lung cancer surgery: introducing MERITS (Multi-centre Evaluation of Renal Impairment in Thoracic Surgery)Naruka, V. / Khushiwal, R. / Clayton, J. / Aresu, G. / Peryt, A. / Mackay, J. / Coonar, A. et al. | 2019
-
Survival following radical radiotherapy for satellite or synchronous ipsilateral nodulesWalls, G. / Hanna, G. / Young, L. / Kearney, B.O. / Harney, J. / Eakin, R. / Mcaleese, J. et al. | 2019
-
Gross tumour volume (GTV) delineation on magnetic resonance imaging (MRI), for stage III lung cancer: consensus recommendations needed to ensure contouring consistencyShiarli, A. / Brown, S. / Dubec, M. / Bainbridge, H. / Koh, D. / Lalezari, F. / Van Herk, M. / Wetscherek, A. / Knowles, E. / Faivre-Finn, C. et al. | 2019
-
Stereotactic ablative radiotherapy for second primary lung malignancy arising post-pneumonectomyAriyaratne, H. / Chander, A. / Anderson, A. / Pasciuti, K. / Cooper, E. et al. | 2019
-
Management recommendations of the lung cancer MDT: are they being followed?Anderson, V. / Doe, S. / Ward, A. et al. | 2019
-
Patient characteristics, imaging and treatment of lung carcinoids in a large teaching hospitalAbi Musa Asa'Ari, A.K.A. / Iftikhar, S. / Niazi, M. / Ghosh, S. / Abid, Q. / Satur, C. / Van Pittius, D. Gey / Hussain, I. / Khan, S. / Haris, M. et al. | 2019
-
Usage and knowledge of electronic cigarettes (e-cigs) in young people in ManchesterHarris, M. / Coote, J. / Blank, M. / Girling, I. et al. | 2019
-
PRO-CTCAE vs REQUITE: a comparison of two patient reported outcome (PRO) measurement tools in a lung cancer populationJordan, T. / Califano, R. / Coote, J. / Falk, S. / Harris, M. / Mistry, H. / Taylor, P. / Woolf, D. / Faivre-Finn, C. et al. | 2019
-
The experience of immunotherapy in lung cancer: an audit of immunotherapy use as second-line treatment for metastatic non-small cell lung cancer (NSCLC) in the South Tees regionHairudin, T. / Li, L. / Mansy, T. / Aynsley, E. / Kumar, G. / Masinghe, S. / Peedell, C. et al. | 2019
-
Outcomes for patients with NSCLC on immunotherapy treatment (adenocarcinoma)Khalid, F. / Weston, C. / Enver, M. / Khan, S. / Ahmed, S. et al. | 2019
-
Optimising management of EGFR mutant NSCLC through circulating tumour DNA (ctDNA) monitoringPowell, R. / Kussaibati, R. / Baijal, S. et al. | 2019
-
Real world treatment and outcomes in patients with EGFR mutation positive advanced non-small cell lung cancer: the Kent Cancer Network experienceAngelis, V. / Fenton, M. / Hunter, S. / Shah, R. et al. | 2019
-
A single centre experience of first-line pembrolizumab in stage IV non-small-cell lung cancer (NSCLC)Denslow, R. / Yarde, A. / Brunner, C. / Walther, J. / Botten, J. / Jankowska, P. et al. | 2019
-
Implementing a low-dose CT screening programme for lung cancer into routine NHS practice: the South Tyneside ModelRoss, T. / Athey, S. / Hunter, J. / Fuller, E. et al. | 2019
-
Does pleural fluid volume influence adequacy of samples for immunohistochemistry or molecular testing?Mccracken, D. / Mercer, R. / Bedawi, E. / Hassan, M. / Asciak, R. / Rahman, N. et al. | 2019
-
Human single-stranded DNA protein 1 (hSSB1): a prognostic factor and target for non-small cell lung cancer (NSCLC) treatmentBoucher, D. / Ashton, N. / Suraweera, A. / Burgess, J. / Bolderson, E. / Barr, M. / Gray, S. / Gately, K. / Adams, M. / Croft, L. et al. | 2019
-
One size doesn't fit all. Arguments for and against pathway redesign in a small District General Hospital (DGH) to accommodate the National Optimal Lung Cancer PathwayBolton, S. / Taylor, C. / Webb, A. et al. | 2019
-
Firming up on pulmonary nodules: a nurse-led approachGraves, J. / Hillcox-Smith, A. / Burnham, A. et al. | 2019
-
Resection rates in patients with non-small cell lung cancer and cardiovascular co-morbiditiesWelch, C. / Adlam, D. / Peake, M. / Sweeting, M. / Rutherford, M. / Lambert, P. et al. | 2019
-
Resistance beyond osimertinibPowell, R. / Kussaibati, R. / Baijal, S. et al. | 2019
-
Age is no barrier to radical chemoradiation in locally advanced non-small cell lung cancer (NSCLC)Gomberg, S. / Hiley, C. / Taylor, B. / Ahmad, S. / Smith, D. et al. | 2019
-
Hypofractionated radiotherapy with chemotherapy for stage 3 non-small cell lung cancer: a single centre experiencePatibandla, A. / Mohammed, N. / Brisbane, I. / Mcloone, P. / Hicks, J. et al. | 2019
-
An audit on IASLC compliance of lymph nodes dissection and impact on survival after surgery for non-small cell lung cancerDe Sousa, P. / Mansour, F. / Barbosa, M. / Booth, S. / Klein, H. / Mani, A. / Nizami, M. / Von Crease, C. / Kyparissopoulos, D. / Townsend, E. et al. | 2019
-
The tsunami that is immunotherapy in NSCLCCharalambous, M. / Weston, C. / Khan, M. / Khan, S. / Ahmed, S. et al. | 2019
-
Nail toxicity in a patient being treated with immune checkpoint inhibitorsBotten, J. / Jankowska, P. / Walther, J. / Yarde, A. et al. | 2019
-
Overall survival (OS) of real-world patients with stage IIIb/IV non-small cell lung cancer (NSCLC) initiating epidermal growth factor receptor (EGFR) targeted tyrosine kinase inhibitors (TKI) as first-line treatment in EnglandRigney, U. / Lock, K. / Chen, C. / Escriu, C. et al. | 2019
-
A retrospective comparison of frontline platinum in non-squamous non-small-cell lung cancer in North Wales over 9 yearsWreglesworth, N. / Chauhan, M. / Fuller, C. / Mullard, A. / Bale, C. / Roberts, C. / Innominato, P. et al. | 2019
-
Mesothelioma in women: a retrospective case note audit of the occupational history of women diagnosed with malignant mesothelioma in a DGH 2012–2017Moylan, A. / Squibb, L. et al. | 2019
-
EBUS-TBNA for the diagnosis of lung parenchymal lesionsSingh, R. / Lal, A. et al. | 2019
-
Are endobronchial ultrasound-guided transbronchial needle aspiration samples adequate for PD-L1 testing in non-small cell lung cancer?Falconer, W. / Bhatt, N. / Medford, A. et al. | 2019
-
Implementation of the National Optimal Lung Cancer Pathway: the Nottingham experienceBakewell, F. / Hodgkiss, M. / Nair, A. / Kennedy, C. / Szolin, S. / Perumpalath, B. / Baldwin, D. / Anwar, S. et al. | 2019
-
Enhancing sensitivity to platinum-based therapy by suppressing the novel prognostic factor CDCA3 in non- small cell lung cancerAdams, M. / Burgess, J. / Richard, D. / O'Byrne, K. et al. | 2019
-
Triage of suspected cancer referrals as part of the National Optimal Lung Cancer Pathway (NOLCP): is this acceptable to patients?Brackenborough, K. / Downes, A. / Ivey, S. / Gabriel, L. / Abed El Khaleq, Y. / Powell, H. et al. | 2019
-
Engaging with the National Optimal Lung Cancer Curative Intent Management Pathway: the Bristol experienceTeh, E. / Low, A. / Casali, G. / West, D. et al. | 2019
-
Volumetric analysis for pulmonary nodules surveillance: a retrospective auditRowan, C. / Farmer, N. / Exley, C. / Ameri, A. et al. | 2019
-
Single centre real life experience with first line pembrolizumab in advanced NSCLC in the North West Coast (Lans and South Cumbria)Abdulwahid, D. / Abutaleb, K. / Mirza, A. et al. | 2019
-
Stereotactic ablative radiotherapy for non-small cell lung cancer: early experience in Aberdeen Royal InfirmaryLaws, K. / Duncan, A. / Tan, W.W. / Stilwell, C. / Moleron, R. et al. | 2019
-
Lung cancer in the young: an Irish case seriesPeters, N. / Lucas, M. / Sui, J. / Maceochagain, C. / Mcmorrough, D. / Ryan, A.B. / Ryan, B. / Mccaffrey, J. / Carney, D. / Higgins, M. et al. | 2019
-
The impact of community-based lung cancer screening on smoking behaviour in a deprived populationTraverse-Healy, L. / Balata, H. / Blandin Knight, S. / Armitage, C.J. / Barber, P.V. / Colligan, D. / Elton, P. / Kirwan, M. / Lyons, J. / Mcwilliams, L. et al. | 2019
-
An assessment of the impact of smoking and comorbid conditions on lung cancer outcomesBurke, E. / Docherty, C. / Lin, Y.P. / Woodhouse, L. / Patel, A.R.C. et al. | 2019
-
Missing the boat: real world analysis of second line osimertanib use across North West LondonEvans, J. / Sita-Lumsden, A. / Black, J. / Mackay, K. / Bendle, M. / Hatcher, O. / Power, D. / Newsom-Davis, T. et al. | 2019
-
Cells and DNA: quality improvement (QI) initiative for molecular tests from cytology samplesBhagwat, P. / Du Parcq, P. / Khorashad, J. / Harper, J. et al. | 2019
-
Brain imaging prior to radical radiotherapy for NSCLCClosier, P. / Cox, R.A. / Frim, O. et al. | 2019
-
Human single-stranded DNA protein 1 (hSSB1): a new prognostic tool and target for non-small cell lung cancer treatmentBoucher, D. / Ashton, N. / Suraweera, A. / Burgess, J. / Bolderson, E. / Barr, M. / Gray, S. / Gately, K. / Adams, M. / Richard, D. et al. | 2019
-
Multiplex PCR testing of diagnostic lung cancer tissue samples for commonly mutated oncogenesSnead, D.R. / Thomas, M. / Nyoni, J. / Wotherspoon, T. / Cree, I.A. et al. | 2019
-
Outcomes for patients with NSCLC on immunotherapy treatment (squamous)Khan, M. / Weston, C. / Charalambous, M. / Khan, S. / Ahmed, S. et al. | 2019
-
University Hospitals North Midlands outcomes from sequential chemo-radiotherapy in non-small cell lung cancerBest, J. / Giridharan, S. et al. | 2019
-
A local qualitative study exploring facilitators and barriers to effective lung cancer decision makingAdizie, J. / Kadiri, S. / Ismail, I. / Woolhouse, I. / Turner, A. et al. | 2019
-
Clinical outcomes related to smoking status in the era of single-port VATS resection for non-small cell lung cancerGleeson, H.V. / George, H.A. / Hocknell, E. / Rao, J.N. / Socci, L. / Tenconi, S. / Hopkinson, D.N. / Edwards, J.G. et al. | 2019
-
An audit into the use of bisphosphonates for patients with non-small cell lung cancer and bone metastases at a tertiary cancer centreBroadbent, R. / Lindsay, C. / Blackhall, F. et al. | 2019
-
A single centre experience of anti-PDL1 and anti-PDL agents in the treatment of thoracic malignanciesChoy, J. / Chang, Y. / Newsom-Davis, T. et al. | 2019
-
Managing elderly patients with lung cancer: is there a need for onco-geriatrics?Brunner, C. / Bennett, S. / Jankowska, P. et al. | 2019
-
Understanding patients' psychological responses to low-dose CT lung cancer screening to inform the development of a training resource for nursesKummer, S. / Waller, J. / Ruparel, M. / Mcewen, A. / Janes, S. / Quaife, S. et al. | 2019
-
Improving the assessment of cardiovascular and respiratory risk factors in radically treated non-small cell lung cancer (NSCLC) using quality improvement methodologyRobinson, S. / Liu, W. / Anand, G. et al. | 2019
-
Managing osteonecrosis of the jaw related to denosumab in patients with lung cancerWenban, C. / Mitchell, L. / Khan, S. / Ahmed, S. et al. | 2019
-
Lung cancer 2-week wait referrals, implentation of a new serviceSmith, R. / Galt, J. et al. | 2019
-
Preoperative mediastinal staging throughout Northern IrelandKhan, R. / Burnside, N. et al. | 2019
-
The benefits of web-based clinician-led daily tracking of lung cancer diagnostic pathwaysGrundy, S. / Taylor, M. / Kelly, P. / Hyde, P. / Macdougall, M. et al. | 2019
-
Banf1 as a marker of lung cancer cell sensitivity to cisplatinPlowman, J. / Bolderson, E. / Burgess, J. / Richard, D. / O'Byrne, K. et al. | 2019
-
SABR implementation at a regional cancer centre: first-year outcomes and challenges at the Kent Oncology CentreForner, S. / Cominos, M. / Brown, J. / Burcombe, R. / Hall, J. / Hadaki, M. / Brulinski, P. / Sevitt, T. et al. | 2019
-
One-year survival data for lung cancer at the Princess Alexandra NHS TrustAghadiuno, T. / Keshwani, K. / Wasin, Z. / Papadatos-Pastos, D. / Chowdhury, S. et al. | 2019
-
Intratumoral heterogeneity in PD-L1 expression in pleomorphic lung carcinoma: implications for management of stage III diseaseJanuszewski, A. / Chang, W. / Zhang, Y.Z. / Laggner, U. / Bowman, A. / Adefila-Ideozu, T. / Moffatt, M. / Cookson, W. / Nicholson, A.G. / Popat, S. et al. | 2019
-
Radical radiotherapy alone versus chemoradiotherapy for the treatment of stage III (N2) non-small cell lung cancerMcaleese, J. / Tumelty, K. / Gillott, C. / Eakin, R. / Harney, J. / Young, L. / Walls, G. / Hanna, G. et al. | 2019
-
A retrospective analysis of lymphopenia rates during and after sequential and concurrent radical chemoradiotherapy for patients with stage III non-small cell lung cancer (NSCLC)Westley, R. / Philipps, L. / Lock, I. / Ahmed, M. / Mcdonald, F. et al. | 2019
-
Evaluation of potential implementation of proposed 28-day cancer waiting time standard at Oxford University Hospitals NHS Foundation TrustGalante, J.R. / Shaw, A. / Gandhi, S. / Harrogate, E. / Sykes, A. et al. | 2019
-
Implementation of network-wide mesothelioma MDT and the effect on patient outcomesHobden, D. / Powrie, D. / Yung, B. / Dancey, G. / Mediros, F. / Muthukumar, D. / Lawson, M. et al. | 2019
-
Attitudes to, and symptom awareness of lung cancer in Ireland: findings from a global consumer pollMcnamara, A. / O'Hagan, K. / Deegan, A. et al. | 2019
-
Developing a nurse consultant-led immunotherapy services in a district general hospitalMuthukumar, D. / Sheen, L. / Rubasingham, J. / Saunders, E. et al. | 2019
-
A single centre experience of anti-PDL1 and anti-PD1 agents in treatment of non-small cell lung cancer (NSCLC)Saunders, E. / Rubasingham, J. / Muthukumar, D. / Ingle, C. et al. | 2019
-
Radial endobronchial ultrasound for the diagnosis of malignant peripheral pulmonary lesions deemed unsuitable for percutaneous CT guided biopsy in a regional 'Difficult Thoracic Biopsy' serviceTariq, S. / Balata, H. / Martin, J. / Lyons, J. / Crosbie, P.A.J. / Booton, R. / Evison, M. et al. | 2019
-
Analysis of patients referred to lung cancer MDM due to diagnosis of lung cancer made during an acute emergency admission in South Eastern HSC TrustJamaludin, J. / Bailey, M. / Rowan, S. et al. | 2019
-
Evidence-based best practices for EGFR and EGFR T790M mutation testing in non-small cell lung cancer (NSCLC) in the UKWelch, L. / Butler, R. / Taniere, P. / Thompson, L. / Oniscu, A. / Clarke, C. / Burghel, G. / Collins, N. / Timm, L. et al. | 2019
-
Does endobronchial ultrasound (EBUS) fine needle aspirate provide sufficient tissue for molecular markers?Gabriel, L. / Brackenborough, K. / Higton, A. / Hughes, N. / Macintyre, J. / Powell, H. et al. | 2019
-
Toxicities and acute oncology service demand of patients receiving immunotherapy for NSCLC: single centre experienceClosier, P. / Sephton, M. / Cox, R.A. et al. | 2019
-
Smoking cessation: an important, simple and yet forgotten intervention!Hamigi, I. / Muneer Ahmed, S. / Khan, S. et al. | 2019
-
Lung adenocarcinoma with ROS1 rearrangement presenting with bilateral organizing pneumonia: a case reportAslam, S. / Jeffs, Y. / Jessop, S. / Collins, S. / Azher, M. / Thomas, E. / Gillespie, L. / Barclay, C. / Vohra, V. / Maidment, G. et al. | 2019
-
Large thoracic mass: an unsual presentation of Hodgkin's lymphomaNiazi, M. / Irshad, S. / Haris, M. et al. | 2019
-
Concurrent chemoradiation in limited stage small cell lung cancer (LS-SCLC): an analysis of survival and toxicityMatthews, S. / Iqbal, M.S. / Mcmenemin, R. / Atherton, P. / Mulvenna, P. / Kovarik, J. / Simmons, T. / Singhal, S. / Mcdonald, F. / Turnbull, H. et al. | 2019
-
Short versus long course of palliative radiotherapy for symptom control irradiating chest in lung cancer patientsBelikova, H. / Hicks, J. et al. | 2019
-
Acute radiation induced CT changes after stereotactic ablative body radiotherapy for primary non-small cell lung cancerSaxby, H. / Chandy, E. / Phillips, I. / Prakash, V. / Ezhil, V. et al. | 2019
-
Experience of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC): an analysis of treatment response and survival outcomeIqbal, M.S. / Pickles, R. / Mackenzie, L. / Burns, A. / Turnbull, H. / Atherton, P. et al. | 2019
-
Real world practice patterns for NSCLC patients in an Irish setting: a multi-centre study on targetable gene alterations and PD-L1 expressionKee, W. / Mullally, W. / Dennehy, C. / Greene, J. / Kelly, D. / Bambury, R. / Bird, B. et al. | 2019
-
Medical thoracoscopy in a DGH: 1-year activityMackenzie, J. / Fairbairn, I. / North, F. / Quirie, C. et al. | 2019
-
Trustwide audit of percutaneous lung biopsy (PLB): delays and complication ratesPegg, E. / Maddock, M. / Slaney, P. / Elliott, S. / Wilson, P. et al. | 2019